Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Testosterone, TRAVERSE, And A Label Change 15 Years In The Making
Mar 21 2025
•
By
Bridget Silverman
The label revisions for testosterone are the visible results of an extensive safety review.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Drug Review Profiles
More from Drug Safety